This dual benefit of appetite control and blood sugar regulation is one reason why GLP-1 agonists are considered a promising treatment for both obesity and type 2 diabetes
Behavior change is what makes the difference, and our latest randomized trial shows Noom members kept losing weight for a full year after the program ended
Theyll also review other medications you take, since bupropion can interact with certain antidepressants, ADHD medications, or substances that lower seizure threshold
Another study concluded that GLP-1s didnt affect psychiatric symptoms in 29 people with bipolar disorder or depression
Microdosing is a newer, gentler approach designed to improve tolerability and make GLP-1 more accessibleespecially for those who arent seeking dramatic weight loss, but want the other benefits of optimal metabolic health
All participants gave written informed consent before enrollment into the study